(NURE) Nuveen Short-Term REIT - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US67092P7069 • Real Estate
NURE: Real Estate, Investment Trusts, US Equities
The Nuveen Short-Term REIT ETF (BATS:NURE) is designed to provide exposure to the U.S. real estate sector through a concentrated portfolio of Real Estate Investment Trusts (REITs). The fund adheres to an 80% investment policy, meaning it allocates at least 80% of the sum of its net assets and any borrowings for investment purposes to REITs. This approach ensures a focused exposure to the real estate market, targeting equity REITs that generate most of their revenue from property ownership and operations. The fund is non-diversified, allowing it to take larger positions in select securities, which can lead to higher volatility but also potentially higher returns.
The ETF tracks a subset of the Dow Jones U.S. Select REIT Index, which includes equity REITs listed on U.S. national securities exchanges. To qualify for inclusion, these REITs must derive at least 75% of their total revenue from real estate assets and have a minimum market capitalization of $200 million at the time of inclusion. This methodology ensures that the fund focuses on established, revenue-generating real estate companies. The funds structure allows investors to gain access to the U.S. real estate market through a single, liquid traded instrument. Additional information about the fund can be found at the Nuveen website: http://www.nuveen.com.
From a technical perspective, NURE is currently trading at $32.39, slightly above its 20-day moving average of $31.86 and 50-day moving average of $31.54, but near its 200-day moving average of $31.88. This suggests the fund is in a period of consolidation. The Average True Range (ATR) of 0.41 indicates moderate volatility, while the average 20-day volume of 9,856 shares reflects moderate trading activity. The funds assets under management (AUM) of $51.93 million suggest a smaller but still viable ETF in the real estate category.
3-Month Forecast: Based on the providedAdditional Sources for NURE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NURE ETF Overview
Market Cap in USD | 44m |
Category | Real Estate |
TER | 0.35% |
IPO / Inception | 2016-12-19 |
NURE ETF Ratings
Growth Rating | 35.5 |
Fundamental | - |
Dividend Rating | 64.1 |
Rel. Strength | -10.7 |
Analysts | - |
Fair Price Momentum | 27.32 USD |
Fair Price DCF | - |
NURE Dividends
Dividend Yield 12m | 3.68% |
Yield on Cost 5y | 6.10% |
Annual Growth 5y | 7.54% |
Payout Consistency | 82.5% |
NURE Growth Ratios
Growth Correlation 3m | -41.7% |
Growth Correlation 12m | 27.9% |
Growth Correlation 5y | 38.1% |
CAGR 5y | 9.90% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 1.59 |
Alpha | -1.11 |
Beta | 0.582 |
Volatility | 33.86% |
Current Volume | 7.2k |
Average Volume 20d | 6.2k |
As of April 19, 2025, the stock is trading at USD 29.28 with a total of 7,200 shares traded.
Over the past week, the price has changed by +3.60%, over one month by -5.55%, over three months by -6.20% and over the past year by +4.56%.
Partly, yes. Based on ValueRay Analyses, Nuveen Short-Term REIT (BATS:NURE) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.50 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURE as of April 2025 is 27.32. This means that NURE is currently overvalued and has a potential downside of -6.69%.
Nuveen Short-Term REIT has no consensus analysts rating.
According to ValueRays Forecast Model, NURE Nuveen Short-Term REIT will be worth about 29.9 in April 2026. The stock is currently trading at 29.28. This means that the stock has a potential upside of +2.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.9 | 2.1% |